Phase 3 trial results show enlicitide, a once-daily oral PCSK9 inhibitor, cut LDL cholesterol by about 60% in high-risk ...
In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.
In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of ...
Interview insights explain how GLP-1R agonists access brain regions governing reward, motivation, and stress. Animal studies ...
Scholars warn that replacing animal testing too quickly may threaten drug safety. As the FDA promotes AI and organoids, ...
Researchers found that individuals have distinct baseline levels of brain-derived proteins in cerebrospinal fluid, masking ...
A large genetic analysis identified 66 high-confidence genes linked to anxiety disorders across major brain regions. Findings ...
Researchers found that cumulative exposure to disadvantaged neighborhoods predicted faster epigenetic aging across three ...
Scientists identified the gene-expression profile of sleeping nociceptors, sensory neurons that drive spontaneous neuropathic ...
Researchers identified FABP4 as a driver of MASLD-related liver cancer. They developed a monoclonal antibody that neutralizes ...
Researchers enhanced natural killer cells from people with HIV to target viral reservoirs. The lab-expanded cells reduced hidden virus, raising the possibility of long-term HIV control without daily ...
Researchers have developed a device that cuts protein sample consumption by as much as 97% while still producing high-quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results